Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
Benjamin A. Krishna(University of Cambridge), John Sinclair(University of Cambridge), Mette M. Rosenkilde(University of Copenhagen), Sebastian Voigt(University of Duisburg-Essen), Katja Spieß(University of Copenhagen), Betty Lau(University of Cambridge), Thomas N. Kledal(Technical University of Denmark), Emma Poole(Addenbrooke's Hospital)
Cited by 80
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
Cross-reactive CD4 <sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
|Science|2021|315
Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74
|Journal of Biological Chemistry|1999|185